According to Orchard Therapeutics 's latest financial reports the company's current EPS (TTM) is -6,45ย โฌ. In 2020 the company made an earnings per share (EPS) of -13,91ย โฌ an increase over its 2019 EPS that were of -15,89ย โฌ.